| 2941.30.00 | 00 | Tetracyclines and their derivatives; salts thereof | g | Free | | 25% |
| 2942.00.03 | 00 | [2,2'-Thiobis(4-(1,1,3,3-tetramethyl-n-butyl)- phenolato)(2,1)]-O,O',S-(1-butanamine), nickel II | kg | Free | | 15.4¢/kg + 46.5% |
| 2942.00.10 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 2.9% (SG) | 15.4¢/kg + 46.5% |
| 3002 | | Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: | | | | |
| 3002.10.01 | | Antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes | | Free | | Free |
| 3002.30.00 | 00 | Vaccines for veterinary medicine | kg | Free | | Free |
| 3004 | | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: | | | | |
| 3004.10.10 | 10 | For veterinary use | kg | | | |
| 3004.10.50 | 10 | For veterinary use | kg | | | |
| 3004.20.00 | 10 | For veterinary use | kg | | | |
| 3004.20.00 | 30 | Tetracycline, singles or in combination with other antibiotics | kg | | | |
| 3004.32.00 | 00 | Containing corticosteroid hormones, their derivatives or structural analogues | kg | Free | | 25% |
| 3004.39.00 | 10 | For veterinary use | kg | | | |
| 3004.40.00 | 05 | For veterinary use | kg | | | |
| 3004.40.00 | 20 | Medicaments primarily affecting the central nervous system: | | | | |
| 3004.40.00 | 60 | Medicaments primarily affecting the eyes, ears or respiratory system | kg | | | |
| 3004.50.50 | 05 | For veterinary use | kg | | | |
| 3004.90.91 | 03 | For veterinary use | kg | | | |
| 3004.90.91 | 65 | Preparations primarily affecting the electrolytic, caloric or water balance: | | | | |
| 3004.90.91 | 22 | Medicaments primarily affecting the central nervous system: | | | | |
| 3004.90.91 | 24 | Tolmetin sodium dihydrate | kg | | | |
| 3004.90.91 | 50 | Medicaments primarily affecting the digestive system: | | | | |
| 3005 | | Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes: | | | | |
| 3005.10.10 | 00 | Coated or impregnated with pharmaceutical substances | kg | Free | | 20% |
| 3005.90.10 | 00 | Coated or impregnated with pharmaceutical substances | kg | Free | | 20% |
Harmonized Tariff Schedule of the United States inquiry: gaming
